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Abstract
Increasingly, the research community applies magnetophoresis to micro and nanoscale particles
for drug delivery applications and the nanoscale rheological characterization of complex
biological materials. Of particular interest is the design and transport of these magnetic particles
through entangled polymeric fluids commonly found in biological systems. We report the
magnetophoretic transport of spherical and rod-shaped particles through viscoelastic, entangled
solutions using lambda-phage DNA (λ-DNA) as a model system. In order to understand and
predict the observed phenomena, we fully characterize three fundamental components: the
magnetic field and field gradient, the shape and magnetic properties of the probe particles, and the
macroscopic rheology of the solution. Particle velocities obtained in Newtonian solutions
correspond to macroscale rheology, with forces calculated via Stokes Law. In λ-DNA solutions,
nanorod velocities are 100 times larger than predicted by measured zero-shear viscosity. These
results are consistent with particles experiencing transport through a shear thinning fluid,
indicating magnetically driven transport in shear thinning may be especially effective and favor
narrow diameter, high aspect ratio particles. A complete framework for designing single-particle
magnetic-based delivery systems results when we combine a quantified magnetic system with
qualified particles embedded in a characterized viscoelastic medium.
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INTRODUCTION
Micro and nanoscale magnetic particles attract much attention in research as probes that
reveal the microrheological properties of biological polymer systems and as potential drug
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carriers in clinical settings. Because of this, the use of magnetophoresis is ever increasing,
becoming more common in diagnostic and analytical devices,17 general research
techniques,1,10,24 and clinical applications.33 Owing to rapid development, this latter area of
medical science employs magnetophoretic systems for drug delivery,3,28,36 gene
transfection,7 and hyperthermic therapies,11,38 where the delivery of a particle to a specific
target is critical. Materials encountered in these biomedical applications such as tissue,
extracellular matrix (ECM), cytoplasm, and synovial fluid contain complex microstructures,
which challenge particle transport. Confined paths in dense meshes necessitate the use of
nanoscale particles, where the flexibility of the mesh in viscoelastic solids or liquids results
in complex rheological behavior and requires the consideration of high shear rate effects.
For example, where some biomaterials such as the ECM exist as viscoelastic solids (gel),
synovial fluid is an entangled polymer system that exhibits yield phenomena and shear
thinning.20 Furthermore, the question of particle shape arises as one balances considerations
of drug loading, force generation, and transport (drag) effects. Solving these challenges will
open new opportunities for the transport of particles and for applications of magnetophoresis
in medical science.
The use of magnetophoresis to manipulate particles predictably in these challenging
biological environments demands a quantitative understanding of the forces required to
produce transport. Despite the increased use of magnetophoresis over a broad range of
fields, limited studies have investigated quantitative microparticle magnetophoresis within
the context of a well-characterized system.1 To date, there are no articles in microstructured
biological media relevant to practical biomedical applications that establish full
characterizations of applied forces, particle and media properties, alongside single particle
measurements. Kuhn et al. showed effective transport for a solution of magnetic particles
with observations at the macroscale that measured bulk fluid transport.22 In a later article,
Kuhn et al. focused on the effects of the particle chemistry and showed increased rates of
transport for nanoparticles functionalized with a proteolytic colleganase.21 The aim of this
study is to develop a predictive understanding of particle magnetotransport that may be used
for the design of drug delivery carriers in medical applications. To that end, we require well-
characterized biofluid media, particles, and magnetic fields as well as single particle
transport measurements.
The concentrated solutions of lambda-phage DNA (λ-DNA) used here function as useful
models of entangled networks typically found in biological media and exhibit complex
rheological phenomena. DNA has several advantages over other biopolymer systems that
might otherwise be suitable models. It contains a highly monodispersed distribution of
polymer lengths which is atypical in synthetic polymer systems, allowing for predictable and
reproducible rheological properties from one DNA sample to the next. DNA has a
persistence length that is intermediate between synovial fluid and the filaments of ECM
(collagen) and cytoplasm (actin, microtubules). In addition, it serves as a model for infected
mucus which may contain a high percentage of entangled DNA.32 For the purposes of this
article, the measured macroscale rheological properties of the λ-DNA solutions are
sufficient to explain our transport data. Using these rheological properties, we can predict
the forces required to move a sphere or rod through a shear thinning material like λ-DNA.
For probe particles, we used commercial micron diameter spheres and fabricated nanorods
with nominal diameters of 200 nm. We characterized the latter with regard to shape and size
using scanning electron microscopy, and measured their magnetic properties using SQUID
magnetometry. Finally, we implemented a simple magnetics system with a characterized
field and field gradient whose magnitudes are suitable for deployment in medical
applications.
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For quantitative magnetophoresis and the understanding of particle shape effects, we first
show that calculated and measured transport velocities agree in the transport of the
microbeads and the nanorods moving in a Newtonian viscosity standard. Following
calibration of the magnetophoretic system, we investigated particle transport in λ-DNA
solutions at two concentrations within the entanglement regime. Particles traveled at
velocities over 100 times faster than expected based on Stokes Law and the low shear rate
viscosity of the λ-DNA solutions. We inferred the viscosities from the calculated forces and
measured velocities, and determined that the viscosities seen by the particles decreased with
increasing particle velocity. This phenomenon is consistent with our measurements of shear
thinning in λ-DNA solutions, and results when an applied shear stress aligns the polymer
strands in a semi-dilute or entangled network16 or disrupts the size and arrangement of
aggregate polymer strands in solution.31 While shear thinning has been measured for λ-
DNA using bulk rheological techniques,13 this is the first article on shear thinning of a
polymer network induced by submicron-sized driven particles. These results have profound
implications regarding transport in biomaterials where a short delivery time is a common
requirement. Such applications often have practical constraints where the magnitude of
driving forces is limited. Demonstrating that particles can induce shear thinning at the
submicron scale reduces the force requirements for a magnetophoresis system or might
provide faster transport over greater distances than one might otherwise anticipate.
METHODOLOGY
This article describes the motion of magnetic particles under an applied magnetic field. The
force balance Fm = Fd describes particle dynamics in low Reynolds number situations where
Fm is the applied magnetic force, and Fd is the drag force due to the fluid. The former
depends on particle magnetic properties, and the magnitude and gradient of the magnetic
field. The latter depends on the medium properties and the particle geometry. We first
describe particle magnetic properties, followed by a characterization of medium properties
and particle geometry. The characterization of these quantities follows thereafter.
Nanoparticles
The particles used in this study were non-magnetic 1 μm polystyrene control beads
(Polysciences, Warrington, PA), superparamagnetic 1 μm carboxy-functionalized MyOne®
microspheres (Invitrogen, Carlsbad, CA) and nickel rods fabricated in house. Highly
monodisperse, the MyOne bead radius was 525 nm, as reported by the manufacturer and
confirmed by our in-house SEM measurements. We used electrochemical deposition to
fabricate nickel rods inside 200 nm pores in a commercially available anodized alumina
oxide (AAO) template (Whatman, Maidstone, UK). The nickel rods varied in length from 5
to 20 μm. This range in rod length provided us with a range of aspect ratios, none of which
was below 15. These large aspect ratios allowed us to approximate a nanorod as a prolate
ellipsoid to estimate the magnetomotive force induced by the source magnet and the shear
rate along the surface of the rod. We adopted the electrochemical plating bath and deposition
parameters from a method devised by Neilsch et al.27 After dissolving the membrane,
ultrasonication suspended the freed rods into a 0.01% SDS solution that we later exposed to
a magnetic field in excess of 0.4 T.
Magnetic Characterization of Nanoparticles
A Superconducting Quantum Interference Device (SQUID) magnetometer (Quantum
Design, Inc., MPMS-5S) measured the magnetic characteristics of the beads and rods at
room temperature. Because their long axis was always parallel to the applied magnetic field
during experiments, we characterized the nickel rods as a vertically aligned array while
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being still embedded inside their host template. We measured the physical dimensions of the
particles using electron and optical microscopy.
Newtonian Fluid and Viscoelastic λ-DNA Solution
Needing a viscous, Newtonian standard to calibrate the magnetophoretic system, we used
Light Karo Syrup (ACH Food Companies, Inc.), a commercial product derived from corn.
For our viscoelastic polymer system, we prepared solutions of λ-DNA (Invitrogen, Carlsbad,
CA), first being careful to anneal one of the single-stranded, hanging ends with a
complementary 12 base pair oligonucleotide (UNC oligonucleotide synthesis facility,
Chapel Hill, NC), which prevented the formation of cyclic DNA, and minimized potential
solution heterogeneity.5
A solution of λ-DNA reaches its overlap concentration at 0.07 mg/mL, and its entanglement
concentration is roughly 10 times that at 0.7 mg/mL.40 We prepared all λ-DNA solutions
from a stock solution of 2.4 mg/mL. Test conditions for nanoparticle experiments included
two λ-DNA solutions within the entanglement regime at 0.7 and 2.0 mg/mL. Owing to the
large quantity of solution needed for cone and plate (CAP) rheometry, we restricted the
macroscale viscometry measurements to a solution at 1.4 and 0.7 mg/mL. The agreement
between our data and literature values and the consistency of the concentration-dependent
rheology of λ-DNA solutions supported this limited application of CAP. We checked for
non-specific adsorption of λ-DNA to the particles, which might confound driven transport,
by imaging suspensions of particles dispersed in λ-DNA, fluorescently labeled with
YOYO-1 (data not shown). We observed no significant increase in fluorescence near these
particles, indicating little λ-DNA adsorption (Table 1).
Viscometry of Transport Media
A controlled-stress cone and plate rheometer (TA Instruments, model AR-G2) measured the
viscometry of the Newtonian and λ-DNA solutions at 23 °C with a 40 mm, 1° cone across
feedback-controlled input shear rates ranging from 1 to 1000 s−1. We fit the viscometry data
for the λ-DNA solutions to a Carreau-Yasuda model,
(1)
where η0 and η∞ are the medium viscosities at zero and infinite shear, respectively, λ is the
thinning time constant, a modulates the width of the thinning regime, and n is the flow-
behavior index that leads to the power-law slope equal to (n − 1).13 Following the method
used by Heo and Larson, we tried first to fit our data to a Cross model, which is one-
parameter simpler than the Carreau-Yasuda model for shear thinning. We found that
whereas the Carreau-Yasuda model provided sufficient parameters to fit the observed
behavior, the Cross model did not. Also, because we compared our data with Heo and
Larson, we chose the Carreau-Yasuda model for consistency.
Microparticle Magnetophoresis Apparatus
The microparticle magnetophoresis apparatus consisted of a 1-in.-long cylindrical rare earth
(NdFeB) permanent magnet (K&J Magnetics, Inc.) mounted on a translation stage and an
inverted optical microscope. The sample, enclosed in a transparent microfluidic chamber,
contained nanoparticles dispersed in a small volume of test fluid (Fig. 1, inset). Adjustments
made to the axial position of the magnet with respect to the sample exposed the particles to
variable forces during magnetophoresis experiments. We used a digital Gauss/Teslameter
Model 5080 (W. Bell, Orlando, FL) to measure the magnitude of the magnetic field applied
to the particles as a function of distance from the axial face of the magnet. We determined
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particle positions by taking time-lapse images of the driven particles using a microscope.
The image-acquisition system consisted of a Pulnix camera, model PTM-6710CL (JAI, Inc.,
San Jose, CA), an EDT-PCI DV (Engineering Design Team, Beaverton, OR) frame grabber
card, and a PC workstation. The CISMM Video Spot Tracker software (http://
cismm.cs.unc.edu/downloads/) handled particle tracking while MATLAB routines computed
velocities. We mounted the entire experimental apparatus onto a floating optics table to
minimize mechanical vibrations.
A microliter-sized volume chamber contained the sample of particles dispersed in the media.
We constructed a sealed sample well from a 50-μm-thick sheet of polydimethylsiloxane
(PDMS) containing a 1.5-mm-round hole and two glass coverslips. The diameter of the
sample well was less than the width of the magnet to minimize lateral variations of the
magnetic field within the sample chamber. Before applying any magnetic field and
collecting data, the sample rested for at least 10 min to ensure the sample reached
hydrodynamic equilibrium. Each particle suspension contained non-magnetic particles as
well as magnetic particles, enabling a quantitative measure of remaining drift. We subtracted
the velocities of the control particles to correct magnetically-driven particle velocities.
Modeling and Measuring Field and Field Gradient
Deriving from first principles, the magnitude of the magnetic field Bm of a cylindrical source
as a function of the axial distance from the face is
(2)
where Ms is the magnetic saturation of the magnet, z is the axial distance from the face of
the magnet, Lm is the length of the magnet, and Rm is the magnet radius. We measured Bm
of the permanent magnet as a function of z from the face of the magnet (Fig. 1), collecting
values at lengths that ranged from the magnet face to 18 mm away. During magnetophoresis
experiments, the nanoparticles were always within a range of 3–10 mm from the magnet
face (Fig. 1).
Using least-squares regression, we fit the magnetic field as a function of distance in the z
direction, Bm(z), over the experimentally relevant z range (Eq. 2). We calculated the axial
distance-dependent field gradient of the magnet in the z direction, , by taking the
derivative of Eq. (2) with respect to z (Eq. 3) and substituting the variable values obtained
through the fit procedure.
(3)
Quantitative Microparticle Magnetophoresis
We describe the magnetic driving forces, , applied to the particles in this study as
(4)
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where the effective magnetization of the particles  is a function of the magnetic
induction  and the magnetic properties of the particles. In addition to ,  is a function
of . Under the experimental conditions of this study,  is, therefore, proportional to 
and . The relation that defines the magnetic force on a sphere 9,26 is
(5)
where Vs and μr are the volume and the relative permeability of the sphere, respectively. We
use the standard definition of relative permeability, μr = μ/μ0, which is the ratio of material
permeability to the permeability of free space. We can show that the force exerted on a
cylinder, Fc, approximated by a prolate ellipsoid with an aspect ratio greater than 20, is
(6)
where Vc is the cylindrical volume, and μr is the relative permeability of the magnetic
material.29
We performed the driven particle transport described here under low Reynolds number
conditions (Re ≪ 1), enabling the correlation of the magnetic driving forces, particle
geometries, and velocities in a Newtonian fluid (corn syrup) through Stokes’ Law. We
compared these empirical magnetophoretic forces with predicted values that were based on
the independently measured magnetic characteristics of the system. Owing to the low
Reynolds number conditions, we set  equal to the magnitude of the frictional drag force
on the particle, .
In general, the frictional Stokes drag force on a particle under such conditions is
, where ν is the particle velocity, η is the medium viscosity, and β is the
geometry coefficient specific to the particle geometry. This relation enables the
determination of the apparent viscosities, ηapp, of the λ-DNA solutions as experienced by
the magnetically driven particles. For a spherical geometry with radius rs, the geometry
coefficient, βs, is simply
(7)
Approximated by Tirado and de la Torre, the geometry coefficient, βc, for an axially
translating cylindrical rod with an aspect ratio greater than 2 is
(8)
where rc is the rod radius, L is the length of the rod, and γ∥ is equal to −0.19, as an end
correction factor.37 Rod motion was always in the axial direction, because the rods align
naturally along their axis length to the field lines that emanate from the drive magnet. The
nickel rods had radii between 100 and 175 nm and a range of different lengths due to
breakage during processing which required an individual calculation of βc for each rod.
Error analysis indicates this range of rod radii would add 10% variability to the viscosity
results.
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One typically applies Stokes Law in particle transport experiments to deduce the applied
force on a particle, with independent coefficients for particle geometry and fluid viscosity.
In order to use Stokes Law to measure fluid viscosity, we need to know the force applied to
the particle. We obtain this in two ways and show their agreement. First, we compute 
for the particles based on Eqs. (5) and (6). Second, we obtain the applied particle force using
, with measured values of η of the Newtonian solution, of the geometries of the
particles, and of their measured velocities. We then use the force on the particle as a
measured quantity and apply a generalized form of Stokes Law to show that our transport
measurements are consistent with the shear rate-dependent viscosity of the λ-DNA
solutions.
Determination of Microscale Shear Rate
For the conversion of bead velocity to shear rate in a viscous fluid, we use the azimuthal
velocity, νθ, of the fluid with respect to the bead
(9)
where rs is the sphere’s radius, r and θ are the radial and angular coordinates for a fluid
parcel that moves with respect to the sphere.2 We find the maximum shear rate component
of the strain rate tensor for a spherical geometry by differentiating νθ with respect to r and
setting r = rs, and θ = π/2. Taking the norm of the tensor yields35
(10)
and similarly, in order to estimate the shear rate along the surface of the nickel rods, we
derived the shear rate magnitude at the top of a prolate ellipsoid (derivation available as
supplemental information) to be
(11)
where rc is the length of the minor axis, and p = L/2rc is the aspect ratio of the cylinder. Data
from the CAP studies of the λ-DNA solution were used to understand the enhanced transport
seen by our nanoparticles. In order to place our measurements within the shear thinning
regime, the Stokes equation is written as , and the velocity is written in terms
of the shear rate according to Eqs. (10) and (11). Finally, we equate the drag and magnetic
forces to obtain a form of Stokes Law that explicitly contains the shear rate:
(12)
(13)
This allows us to plot our transport data in direct comparison with the Carreau-Yasuda
model fits to viscometry data.
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Particle Velocity vs. Shape—The delivery speed of a carrier particle and the number of
deliverable molecules are of paramount significance when one designs a magnetophoretic
drug delivery system because both characteristics depend on particle size and shape. The
magnetophoretic velocity results from a combination of driving and drag forces (Eqs. 12 and
13) applied to the particle, which are related to the volume of magnetized material and the
drag coefficients, respectively.
(14)
Attached to the surface of delivery particles and/or loaded internally, the number of
deliverable payload molecules is a function of the surface area or volume of the particle.
Drag Force vs. Shape—We now compare the choice between spherical and cylindrical
nanoparticles for transport. Under the assumption that both particle shapes studied here have
equal volume, the relationship between the radius of a sphere and the radius and axial length
of a cylinder is , which shows a higher sensitivity to rc over L. Given a
constant particle velocity and Newtonian viscosity, we compute the ratio of the geometry
coefficients as
(15)
For p > 1, we find that βc/βs > 1, resulting in a drag penalty when one switches from a
spherical to a cylindrical shape. For our cylinders p ranges from 15 to 105, corresponding to
an increase in drag of up to 65% (βc/βs ~ 1.65) for the cylinder over that of the sphere.
Magnetic Force vs. Shape—Given the smaller viscous drag coefficient of a sphere vs.
that of an equal volume rod, a researcher might conclude that a spherical particle would
represent the best option for delivery in a biomedical context. However, one must also
consider the effect shape has on the driving force, which does not depend solely on magnetic
content.
When comparing the forces on a sphere (Eq. 5) and cylinder (Eq. 6) made of the same
material and equal volume, the force ratio is
(16)
This ratio must be greater than 1 when using any magnetic material, implying that for these
conditions, Fc > Fs by the factor shown above. For our nickel nanorods, where μr = 18.3,
this results in an applied force that is about 50 times higher for a cylinder than for a sphere
with the same volume.
Viscosity vs. Shear Rate—Because the spheres and cylinders experience different shear
rates, we must recognize the concomitant change in the shear rate-dependent viscosity and
compare the viscosity ratio, ηc(γ̇c)/ηs(γ̇s), via the Carreau-Yasuda model. Because η0 ≫ η∞,
we can approximate η∞ as zero, and because we focus on just the high shear rates in the
thinning regime, we can further simplify the ratio to
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which incorporates an error of 5% for our experiments.
When we combine the effects of magnetic and drag forces (Table 2), we can compute the
composite ratio of particle velocities within 10% error with
(18)
The velocity ratios for the types of particles used in our experiments show a clear bias for
the rod geometry, with approximately 200 times the effective transport rate. The primary
contributor to the effectiveness of rod transport is the force ratio, with the drag and viscosity
ratios mostly canceling each other out.
Shear Rate vs. Shape—Because the rod experiences a larger force than a sphere of equal
volume, it has the potential to experience greater shear thinning due to a higher drift velocity
and therefore a higher shear rate. The γ̇c/γ̇s ratio shows dependence upon the aspect ratio as
well as the flow behavior index, n.
(19)
We used the range of aspect ratios found in our experiments to compute ratios that range
from 7 to 11. These γ̇c/γ̇s ratios indicate a 7–11-fold increase in the shear rate for the
cylinder over the sphere. It is important to note that the cylinder’s high shear rate advantage
vanishes for a Newtonian fluid as it lacks shear rate dependence. In a shear thinning fluid,
however, this increase in the shear rate results in a greater velocity for the rod compared to
the sphere. Access to these higher shear rates allows a rod shaped particle to propagate
almost 10 times more effectively through a lower viscosity medium. We note that a rod-
shaped particle might have additional advantages over a bead in its ability to penetrate the
interstitial spaces and entanglements between polymer molecules in biomaterials, though we
do not explore these advantages in this article.
RESULTS
Solution Viscometry
The Newtonian solution used in this investigation had a zero-shear viscosity of 3.38 ± 0.04
Pa s and was constant for any input γ̇ below 100 s−1 (Fig. 2). The particles driven in this
solution had γ̇ values less than 100 s−1. In contrast, CAP rheometry of a 1.4 mg/mL λ-DNA
solution revealed significant shear thinning at shear rates greater than 0.14 s−1, which
corresponds to a λ of 7 s. The thinning regime extended to the highest shear rates tested, i.e.,
20 s−1. The power-law slope for the thinning regime was −0.96, leaving n = 0.04. Both of
these values for the Carreau-Yasuda model parameters agree well when compared to data
published in Heo and Larson.13 Our data from CAP rheometry of 0.7 mg/mL λ-DNA
solution showed less than 8% average variability when compared to the data published in
Heo and Larson.13 In light of the agreement of our CAP study with published values and
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because of the expense of λ-DNA at the required concentrations and volumes, we fit power-
law slopes to the tested concentrations in Heo and Larson13 and extrapolated to a slope for
our microscale tested concentration at 2 mg/mL. In order to understand the effect
temperature might have on particle transport through the viscoelastic medium, we increased
the temperature of the 0.7 mg/mL λ-DNA solution to 37 °C. The zero-shear viscosity for the
warmer solution was roughly one-half the value of the cooler solution. At higher shear rates,
where shear thinning modes dominate, both rheology measurements converged to a common
relationship independent of both temperatures. The effect that solution temperature had on
particle transport is explained in more detail in the supplementary information.
Nanoparticle Magnetic Properties
Under experimental conditions, the maximum magnetic field experienced by the particles in
our magnetophoresis system was less than 0.06 T, as determined by measurements with a
Hall probe in our permanent magnet system. We obtained excellent fits for the expected
position dependence of the magnetic field for the permanent cylindrical magnet (Fig. 1).
This value sets the relevant range of magnetic fields for the magnetometry measurements of
the microbeads and nanorods.
We measured the magnetic characteristics of the particles to enable the calculation of the
magnetic driving forces applied during magnetophoresis experiments. Using the SQUID
magnetometry data, we determined that, at low fields, the volumetric susceptibility of
MyOne beads was 0.86 ± 0.02 (Fig. 3). From these measurements, the MyOne beads
magnetically saturated at an applied field of 0.5 T and had a saturation magnetization Msat of
53 ± 1 kA/m.
For the nickel nanorods, we found the volumetric susceptibility was 18.3 ± 0.3 based on
magnetometry measurements and the pore density of the membrane (Fig. 3). This value
incorporates a normalization factor26 derived from articles of the magnetic characterization
of similar rods by other researchers6,8,15,25 and accounts for the influence of the rod packing
density on the measured magnetization. In addition to the magnetization induced by the
applied field, the rods showed some ferromagnetic character which resulted in a remanent
magnetization of 39 ± 2 kA/m. The rods saturated at an applied field of 0.4 T and had a Msat
value of 590 ± 30 kA/m.
Magnetic Forces on Particles
Since the magnetic particles did not saturate in our transport measurements, we calculated
 using the magnetic characteristics of the particles and the applied magnetic field (Eqs. 5
and 6). Because  and  for the rods should be proportional to L, we normalized the
force values for each rod by dividing out L, enabling comparisons between individual rods.
The predicted and experimental values of  for both the MyOne beads and the rods
agreed well within the experimental uncertainties as shown in Fig. 4, which lends
confidence to our ability to calculate viscosities of λ-DNA solutions by solving for the η
term using Stokes drag.
Driven Particle Transport in Complex Fluids
In order to understand the nature of driven particle transport in biological fluids, we applied
magnetic forces and drove MyOne beads and rods through λ-DNA solutions at 0.7 and 2.0
mg/mL. Particles experience two different shape-dependent forces, one imparted by particle
magnetization and is proportional to volume, and the other by drag and is proportional to
cross-sectional radius and the apparent viscosity, which is also geometry dependent. In order
to separate the effects of these two forces on transport, we first plot the particle velocity
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normalized by the shape dependence of the drag coefficient vs. , the quantity
responsible for the driving force (Fig. 5). If the particles experienced only the shape-
dependent effects on their drag, and experienced the same viscosity, then their curves in the
same fluid should lie on top of each other. This is approximately the case for the beads and
rods in the Newtonian standard. As expected, particle velocities increase as the magnetic
field and field gradient increase. Focusing on the particle transport in the Newtonian
standard, we see that the nanorods achieve higher normalized velocities than the microbeads
in part due to their higher magnetizations in the same applied fields. We present no data for
MyOne beads in 2.0 mg/mL λ-DNA because we found no measurable displacement on
experimental timescales.
Compared to Newtonian solutions, the relative transport properties of particles are
dramatically different when the medium is a viscoelastic λ-DNA solution. Figure 5 shows
that, relative to the velocity of the particles in a Newtonian fluid, the beads experience
slower velocities while the nanorods experience faster velocities in λ-DNA. In λ-DNA
solutions, nanorods move with >100 times the bead velocity, regardless of the solution
temperature, as opposed to only a fivefold increase when using the Newtonian standard. We
interpret the relative differences in the driven velocities as a change in the apparent media
viscosity ηapp experienced by the particles. These differences result from the responses of
the media to the shear stresses applied by the driven motion of the particles.
In order to investigate the driven particle induced shear thinning of the λ-DNA solutions, we
plot in Fig. 6 the apparent viscosity, ηapp, as measured by the particles as a function of shear
rate. The CAP measurements (shown as red solid lines) reveal the λ-DNA solution as a
shear thinning material at shear rates greater than ~10−1 s−1. The nanoparticles (shown as
discrete points) roughly reproduce the apparent solution viscosity measured by the CAP
irrespective of solution temperature. In conjunction with the maximum shear rate, we plot
the measured rod velocity normalized by length (indicated by green axis and arrows), which
normalizes for the various rod lengths obtained during fabrication.
In contrast to the behavior of the particle motion in the Newtonian standard, the apparent
viscosity of the λ-DNA solution, as derived from particle motion, indicates a power-law
dependence that corresponds to shear thinning of the matrix. In λ-DNA, power-law fits to
the data revealed exponents of −0.8 for rods (both concentrations) and −0.6 for beads (0.7
mg/mL). These power-law exponents are consistent with those measured for λ-DNA by bulk
rheological techniques.13 As expected in all cases, the values of ηapp of the λ-DNA solutions
are greater than the viscosity of pure buffer (10−3 Pa s).
DISCUSSION
With a quantitative understanding of magnetic particle transport in hand, we now relate
these measurements to a set of forces required to deliver particles given the size and shape.
In Fig. 6, we show the force per micron requirements for a rod, driven through 0.7 and 2 mg/
mL λ-DNA solutions (shown in blue, dashed lines), along with the resulting viscosities and
their dependence on velocity and shear rate (shown in red). These lines indicate the force
necessary to achieve a shear rate (black) or velocity (green) when one expects a given shear-
dependent viscosity (red). For example, to deliver a rod within the shear thinning region of
λ-DNA at 2.0 mg/mL with a 10 μm rod at 1 s−1, find the shear rate along the x-axis and
locate the expected viscosity; for this example, the viscosity is 1 Pa s, well within the shear
thinning regime for this material. At this shear rate, also note the force requirement for each
concentration. For 2 mg/mL λ-DNA, one applies ~3 pN to achieve the desired shear rate,
whereas 0.7 mg/mL DNA requires only 0.3 pN.
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There are a variety of physiological contexts where shear thinning particle delivery may be
useful. Here we discuss three: extracellular matrix, mucus barriers, and synovial fluid. In the
context of particle delivery through tissue, Lai et al. used canonical CAP methods to
measure viscosities for a simulated tissue (bovine-hide collagen) as high as 400 Pa s.23
Kong and Vazquez measured the viscoelastic properties of gelled collagen used as an
extracellular matrix simulant and found shear thinning at ~0.05 s−1 with a zero-shear
viscosity at ~1 Pa s.19 Particle delivery through mucus is important for pulmonary or
cervical delivery of drugs. Besseris and Yeates utilized rotating magnetic micron-sized
particles to measure a zero-shear viscosity for canine tracheal mucus that lies between 10
and 7500 Pa s4, and measurements by Powell et al.30 showed that mucus can thin at shear
rates greater than 1 s−1. Our measurements in solutions of DNA are relevant to
measurements of mucus rheology because large amounts of DNA are found in pathological
(i.e., CF) sputum.32 Heo and Larson demonstrated that the application of shear stress results
in shear thinning in λ-DNA at the macro scale where the measured viscosities are
diminished by an order of magnitude or more.13 Delivery of drugs to or through
cartilaginous tissue requires particle transport through synovial fluid and corresponding
measurements by Jay et al.18 in bovine synovial fluid found thinning at shear rates greater
than 0.1 s−1. For the purposes of determining a proper applied force regime for the range of
materials introduced above, we first consider the zero-shear viscosity limit. Initially, to
achieve a 100 nm/s velocity, a 200-nm-diameter rod would require forces ranging from 0.4
to 300 pN per micron in length, with the lower range of force for synovial fluid and the
higher range for mucus. This velocity would correspond to a shear rate of 1.5 s−1, and would
be sufficient to engage shear thinning in any of the aforementioned biopolymer systems. A
bead with the same volume (and thus equal payload) and made from the same magnetically-
permeable material would require 3 to 5 times more force to achieve similar shear rates. In
order to achieve this same magnetomotive force, (B·∇)B would need to be 75 times higher
(assuming no saturation), and therefore requires a larger or closer permanent magnet.
Choosing rod-shaped particles as drug carriers becomes obvious when one considers the
impact of the lower required magnetic fields and field gradients.
A functioning apparatus may not require very large and unwieldy magnets positioned
uncomfortably close to the patient’s body. In this article, we used a rare-earth permanent
source magnet that was relatively small, (2-mm diameter, 1-in. length) which generated a
shear thinning flow for rods at distances as far away as 5 mm in a fluid with rheological
properties comparable to healthy mucus. In terms of source magnet design, the force
generated varies minimally with respect to changes in aspect ratio of the magnet. However,
increasing the radius of the magnet leads to an increased force and increased penetration
depth of the force. In fact, to achieve maximum force at a given depth, a magnet with a
radius of about twice the desired depth is required, but the maximum force for a given depth
is not necessarily required to achieve significant shear thinning. As the magnetomotive force
depends on the product of the field and field gradient, the force generated by a cylindrical
magnet scales as 1/z2 at distances larger than twice the diameter, where z is distance from
the face of the magnet. Our calculations indicate that shear thinning in 2 mg/mL λ-DNA can
be achieved at depths typically seen in the lung (~1 in.)34 with a NdFeB source magnet as
small as 20.5 mm in diameter and 20.5 mm long. We used the magnetization value of our
experimental source magnet to calculate that, a magnet with these specifications, along with
the nickel rods of 0.1 and 1.5 μm in radius and length, respectively, used in this study,
would produce about 0.11 pN of force. As shown in Fig. 6, the force produced would lead to
a 100-fold decrease in viscosity in 2 mg/mL λ-DNA, a relevant model for infected mucus.32
In the context of a drug delivery system, the velocity of the rod shaped particles would be on
the order of 1 μm/s and can, therefore, traverse the approximate length of the mucus layer of
the lung epithelia in seconds and the typical length of a mucus plug in a matter of minutes.
Without the shear thinning of this material, the same particle would travel at the zero shear
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viscosity, or 1000-fold slower, and therefore take 1000 times longer to reach the desired
displacement.
Shear thinning of mucus by these micro-particles opens up a myriad of possibilities in drug
delivery, specifically inhalation delivery. Two main pathways exist for the clearance of
particles transported through the respiratory epithelium: the mucociliary clearance system
and alveolar macrophages.12 The internalization of carrier particles by alveolar macrophages
has been shown to be heavily dependent on particle size. In fact, using carrier particles
smaller than 0.26 μm in diameter, which are within the parameters of the experiments
described here, avoids macrophageal phagocytosis altogether.14 By designing a drug
delivery system that takes advantage of the shear thinning of mucus to increase particle
transport rate, the problems arising from mucociliary clearance can be obviated, increasing
bioavailability of the drug in the lungs. However, in order to get net transport, the particle
motion through the mucus layer to the epithelium would need to compete with the
mucociliary clearance rate, which in a normal human trachea is ~200 μm/s.39 Magnetic-
driven transport in this case may tilt the balance toward effective transfection.
CONCLUSIONS
By using solutions of λ-DNA within the entanglement regime, we demonstrated that the
transport of magnetically driven nanoparticles can induce shear thinning of a polymer
network. The presence of shear thinning indicates that driven particles experience viscosities
in biological materials that are significantly less than the bulk material viscosities as
measured under zero-shear conditions. Consequently, predictions based on zero-shear
viscosity assumptions alone overestimate the force required to obtain sufficient particle
transport. This finding has practical implications for a host of biomedical applications
ranging from drug delivery to hyperthermic therapies, where the rapid particle transport with
minimal driving force is essential.
We fully characterized the magnetophoretic system used in this study, calibrated it using a
Newtonian fluid standard, and confirmed our calibration with SQUID measurements. This
enabled us to predict and quantify magnetic driving forces and viscous drag forces on
individual particles. We found that the magnetic fields and field gradients required to
transport a rod-shaped geometry are easily achieved. Our source was a widely available rare
earth (NdFeB) permanent magnet, and the distance between particles and magnet was in the
millimeter to centimeter range, a relevant scale of driving forces considered practical for
biomedical applications. The combination of a magnetically driven system, fully
characterized probe particles, and a non-Newtonian medium comprise a generic framework
for performing drug-delivery studies.
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Refer to Web version on PubMed Central for supplementary material.
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LIST OF SYMBOLS
a Scales width of shear thinning regime in Carreau-Yasuda model
Magnetic induction
Bm Magnitude of magnetic field
Frictional drag force on particle
Magnetic driving force
L Cylinder length
Lm Length of drive magnet
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r Radial location of fluid moving with respect to sphere
rc Cylinder radius






z Axial distance from drive magnet
β Geometry coefficient
βc Geometry coefficient, cylindrical geometry
βs Geometry coefficient, spherical geometry
γ∥ Correction factor for cylindrical drag in axial direction
γ̇s Shear rate for sphere
γ̇c Shear rate for cylinder
η0 Viscosity of medium at zero-shear
ηapp Apparent viscosity
θ Angular location for fluid velocity
λ Thinning time constant
μ0 Permeability of free space
μr Relative permeability of sphere
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Measured magnetic field as a function of distance from the face of the cylindrical permanent
source magnet with mathematical fit (red, solid). The shaded box represents the field
measurements over the experimentally relevant distance range. Inset: Apparatus. At right is
the axially adjustable cylindrical magnet we use to actuate the microparticles. At left is a
microscope objective where the sample volume resides within a PDMS well (top and bottom
glass coverslips are not shown). The inset shows the time-lapsed paths of magnetically
translating particles as a series of dots.
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The viscosity (ηapp) of the Newtonian standard solution as a function of the applied shear
rate (γ̇max) measured by CAP rheometry (·) and driven particle velocitometry (MyOne beads
◇, nickel rods ○). The viscosity is constant as a function of the applied shear rate, which is
indicative of Newtonian behavior. The CAP rheometer and microparticle probes both
measure the same average viscosity.
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Measured magnetization per MyOne bead or nickel nanorod long axis as a function of the
applied magnetic field (±5 T), measured at 290 K by SQUID magnetometry. We tested the
beads as a dried suspension and the rods as a membrane-bound array. The bead polymer
matrix and the sample holder induce a slight diamagnetic background that we removed by
normalization. We also normalized the sample magnetization with respect to the number of
particles. Beads show an absence of area inside the hysteresis loop, indicating these particles
exhibit only paramagnetic behavior whereas rods show a small amount of remanent
magnetization, indicating a slight ferromagnetic behavior. We define particle saturation at
fields where particle magnetization reaches 95% of its maximum value.
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The average magnetophoretic force applied to MyOne beads (○) and length-normalized
nickel nanorods (●) plotted as functions of the distance from the permanent magnet. The
bars on these data indicate the standard deviation of force as calculated based on the
velocities of individual nanoparticles in the Newtonian standard solution. The black solid
line plots the theoretical force imposed on the beads based on the measured field and
measured magnetic properties of the nanoparticles. The red lines indicate the upper and
lower bounds on the uncertainty of the theoretical force.
Cribb et al. Page 20














Normalized mobilities of rods (■, □) and MyOne beads (●, ○) in the Newtonian solution
(open symbols) and 0.7 mg/mL λ-DNA solutions (closed symbols) as functions of the
magnetic force proportionality B∇B. We normalized the particle mobilities with respect to
their geometry-dependent drag and further normalized the rods with respect to their lengths
in microns. The units of the normalized velocities for the rods and the beads are m2/s per μm
length of the rod and m2/s respectively. The bars on the data points represent the range of
particle velocity and do not indicate measurement error.
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Apparent viscosity (ηapp) as a function of the maximum applied shear rate (γ̇max) in λ-DNA
solutions. The data shown for 0.7 mg/mL as the solid, red lines are macroscale
measurements from Heo and Larson.13 Corresponding lines for 1.4 and 2 mg/mL
concentrations are CAP measurements by our lab and extrapolated values, respectively.
Shown as discrete data points is ηapp as experienced by magnetophoretically driven rods (□,
◇,) in 0.7 mg/mL and 2 mg/mL solutions, where the decrease in ηapp with increasing γ̇max
indicates shear thinning. Also shown are force requirements (blue lines) for translating a 1
μm long rod with a 100 nm diameter through 0.72 and 1.44 mg/mL DNA solutions as a
function of shear rate. Because the DNA solution shear thins, small increments in force yield
much higher particle velocities than expected because of the shear thinning effect.
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TABLE 1
Carreau parameters for λ-DNA test solutions.
DNA Conc. (mg/mL) 0.7 1.4 2.0a
η0 (cP) 1300 3900 17000
η∞ (cP) 5 8 11
λ (s) 5.7 7.1 16
n 0.15 0.038 0.034
a 1.3 1.0 0.8
Testing regime Driven microparticles CAP Driven microparticles
a
Extrapolated from Heo and Larson13 and 1.4 mg/mL CAP data.
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